All Stories

  1. Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients–a pilot study
  2. In Vivo Measurement of GABA Transmission in Healthy Subjects and Schizophrenia Patients
  3. Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk
  4. Brain connection impairments may increase risk for schizophrenia
  5. Insight and neurocognitive functioning in bipolar subjects
  6. Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: An integrated DTI study
  7. Heritability of Subcortical and Limbic Brain Volume and Shape in Multiplex-Multigenerational Families with Schizophrenia
  8. Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia
  9. Persistent Infection by HSV-1 Is Associated With Changes in Functional Architecture of iPSC-Derived Neurons and Brain Activation Patterns Underlying Working Memory Performance
  10. Fitness costs and stability of Cry1Ab resistance in sugarcane borer, Diatraea saccharalis (F.)
  11. Neuroimaging predictors of cognitive performance across a standardized neurocognitive battery.
  12. Exposure to herpes simplex virus, type 1 and reduced cognitive function
  13. Association of variants in DRD2 and GRM3 with motor and cognitive function in first-episode psychosis
  14. HLA associations in schizophrenia: Are we re-discovering the wheel?
  15. RGS4 and COMT risk variants are associated with brain structural alterations
  16. Alterations in the cerebral white matter of genetic high risk offspring of patients with schizophrenia spectrum disorder
  17. Brain activation patterns during visual episodic memory processing among first-degree relatives of schizophrenia subjects
  18. Multivariate prediction of emerging psychosis in adolescents at high risk for schizophrenia
  19. Persistent infection with neurotropic herpes viruses and cognitive impairment
  20. Neurocognitive Performance Stability in a Multiplex Multigenerational Study of Schizophrenia
  21. Exposure to Herpes Simplex Virus Type 1 and Cognitive Impairments in Individuals With Schizophrenia
  23. Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families
  24. Antiherpes Virus–Specific Treatment and Cognition in Schizophrenia: A Test-of-Concept Randomized Double-Blind Placebo-Controlled Trial
  25. A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia
  26. Progressive Gray Matter Loss and Changes in Cognitive Functioning Associated With Exposure to Herpes Simplex Virus 1 in Schizophrenia: A Longitudinal Study
  27. Schizophrenia
  28. Progressive alterations of the auditory association areas in young non-psychotic offspring of schizophrenia patients
  29. Gray matter loss in young relatives at risk for schizophrenia: Relation with prodromal psychopathology
  30. Abnormalities of the corpus callosum in non-psychotic high-risk offspring of schizophrenia patients
  31. Fine-mapping reveals novel alternative splicing of the dopamine transporter
  32. Candidate genes and their interactions with other genetic/environmental risk factors in the etiology of schizophrenia
  33. Neuroprotective Effects of Cognitive Enhancement Therapy Against Gray Matter Loss in Early Schizophrenia
  34. Grey matter changes associated with host genetic variation and exposure to Herpes Simplex Virus 1 (HSV1) in first episode schizophrenia
  35. Do inter-regional gray-matter volumetric correlations reflect altered functional connectivity in high-risk offspring of schizophrenia patients?
  36. Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia
  37. Cortical surface characteristics among offspring of schizophrenia subjects
  38. Dorsolateral Prefrontal Cortex Magnetic Resonance Imaging Measurements and Cognitive Performance in Autism
  39. Grey matter volume reductions in the emotion network of patients with depression and coronary artery disease
  40. Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome
  41. Verbal fluency deficits and altered lateralization of language brain areas in individuals genetically predisposed to schizophrenia
  42. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: A 1H spectroscopy study
  43. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia
  44. Do premorbid impairments predict emergent ‘prodromal’ symptoms in young relatives at risk for schizophrenia?
  45. Synergistic Interactions Between Cry1Ac and Natural Cotton Defenses Limit Survival of Cry1Ac-resistant Helicoverpa Zea (Lepidoptera: Noctuidae) on Bt Cotton
  46. Untreated illness duration correlates with gray matter loss in first-episode psychoses
  47. RGS4 Polymorphisms Associated With Variability of Cognitive Performance in a Family-Based Schizophrenia Sample
  48. Neurological abnormalities among offspring of persons with schizophrenia: Relation to premorbid psychopathology
  49. An integrated psychobiological predictive model of emergent psychopathology among young relatives at risk for schizophrenia
  50. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia
  51. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders
  52. Neuroanatomical substrates of foresight in schizophrenia
  53. Psychopathology among offspring of parents with schizophrenia: Relationship to premorbid impairments
  54. Cannabis use and brain structural alterations in first episode schizophrenia — A region of interest, voxel based morphometric study
  55. Sleep Quality and Architecture in Quetiapine, Risperidone, or Never-Treated Schizophrenia Patients
  56. A network of dopaminergic gene variations implicated as risk factors for schizophrenia
  57. Structural Cerebral Variations as Useful Endophenotypes in Schizophrenia: Do They Help Construct "Extended Endophenotypes"?
  58. Gene-Mapping Studies for Schizophrenia: How Useful Are They for the Clinician
  59. Morphology of the orbitofrontal cortex in first-episode schizophrenia: Relationship with negative symptomatology
  60. Are brain structural abnormalities useful as endophenotypes in schizophrenia?
  61. Cerebellar Volume in Offspring From Multiplex Alcohol Dependence Families
  62. HSV1 exposure affects prefrontal cortical structure in schizophrenia patients
  63. Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia
  64. Neuroscience in Psychiatry Training: How Much Do Residents Need To Know?
  65. Neuroscience in Psychiatry Training: How Much Do Residents Need To Know?
  66. Dorsolateral prefrontal cortex morphology and short-term outcome in first-episode schizophrenia
  67. The nature of brain abnormalities in schizophrenia: What do we really know?
  68. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients
  69. The Entorhinal Cortex in First-Episode Psychotic Disorders: A Structural Magnetic Resonance Imaging Study
  70. Insight and prefrontal cortex in first-episode Schizophrenia
  71. Approaches for adolescents with an affected family member with schizophrenia
  72. Parahippocampal gyrus in first episode psychotic disorders: a structural magnetic resonance imaging study
  73. Formula Method for Stimulus Setting in Bilateral Electroconvulsive Therapy
  74. Neuroimaging of schizophrenia and its development